Medication adherence and medicare expenditure among beneficiaries with heart failure

American Journal of Managed Care

Volumn 18, Issue 9, 2012, Pages 556-563

  Lopert, Ruth ^a   Shoemaker, J Samantha ^b,c   Davidoff, Amy ^b,c   Shaffer, Thomas ^b,c   Abdulhalim, Abdulla M ^b,c   Lloyd, Jennifer ^d   Stuart, Bruce ^b,c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CONGESTIVE HEART FAILURE; COST CONTROL; DRUG COST; HEALTH CARE COST; HUMAN; MEDICARE; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CARDIAC GLYCOSIDES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEART FAILURE; HUMANS; LINEAR MODELS; MEDICARE; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; UNITED STATES;

EID: 84869214776     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. National Center for Health Statistics. Health, United States, 2005, with Chartbook on Trends in the Health of Americans. Hyattsville, MD: NCHS; 2005.
2. Lloyd-Jones D, Adams RJ. Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2010 update: a report from the American Heart Association [published corrections appear in Circulation. 2011;124(16):e425 and Circulation. 2010;121(12):e260]. Circulation. 2010;121(7):e4-e215.
3. National Heart, Lung, and Blood Institute. NHLBI Factbook: HTML/ Web Version. http://www.nhlbi.nih.gov/about/factbook/toc.htm. Published 2008. Accessed March 5, 2010.
4. Russo CA, Elixhauser A. Hospitalizations in the Elderly Population, 2003. Statistical Brief #6. Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports/statbriefs/ sb6.pdf. Published May 2006. Accessed March 5, 2010.
5. Healthcare Cost and Utilization Project (H-CUP), Agency for Healthcare Research and Quality. Overview of the Nationwide Inpatient Sample (NIS). http://www.hcup-us.ahrq.gov/nisoverview.jsp. Published 2000-2001. Accessed March 5, 2010.
6. Agency for Healthcare Research and Quality. Prevention Quality Indicators (PQI) Composite Measure Workgroup Final Report. http://qualityindicators.ahrq. gov/downloads/pqi/AHRQ-PQI-Composite-Final.pdf. Published April 2006. Accessed March 24, 2010.
7. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-2971. (Pubitemid 37510603)
8. Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003;26(6):1786-1801.
9. Gilmer TP, O'Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59-64. (Pubitemid 40095783)
10. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10(2, pt 2):144-151. (Pubitemid 38332389)
11. Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick M, Vijan S. Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005;143(2):89-99.
12. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530. (Pubitemid 40847288)
13. Stuart BC, Simoni-Wastila, L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by US Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-649.
14. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285(2):182-189. (Pubitemid 32048520)
15. Salas M, Hughes D, Zuluga A, Vardeva K, Lebmeier M. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health. 2009;12(6):915-922.
16. Simpson S, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
17. Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med. 1999;131(9):660-667. (Pubitemid 29517951)
18. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153(16):1863-1868. (Pubitemid 23329840)
19. Buccaneer Computer Systems and Service Inc. Chronic Condition Warehouse User Manual. Version 1.6. http://www.ccwdata.org/cs/groups/public/documents/ document/ccw-userguide.pdf. Published 2010. Accessed March 5, 2010.
20. Heart Failure Society Of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12(1):10-38.
21. Heart Failure Society of America; Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2010;16(6):e1-194.
22. Cardiovascular Expert Group. Therapeutic Guidelines: Cardiovascular. Version 5. Melbourne, Australia: Therapeutic Guidelines Limited; 2008.
23. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016.
24. Dickstein K, Cohen-Solal A, Filippatos G, et al ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [published corrections appear in Eur Heart J. 2010;12(4):416 and Eur Heart J. 2010;31(5):624]. Eur Heart J. 2008;29(19):2388-2442.
25. US Department of Labor, Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers. http://www.bls.gov/cpi. Published 2009. Accessed June 15, 2009.
26. Vink NM, Klungel OH, Stolk RP, Denig P. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf. 2009;18(2):159-165.
27. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421-429. (Pubitemid 32097260)
28. Dor A, Encinosa W. How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs. Working paper w10738. Cambridge, MA: National Bureau of Economic Research; September 2004.
29. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-740. (Pubitemid 41608213)
30. Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. The effects of prescription drug copayments on statin adherence. Am J Manag Care. 2006;12(9):509-517. (Pubitemid 44412033)
31. Goldman D, Joyce GF, Escarcea JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350. (Pubitemid 38656301)
32. Nicholson S. The effect of cost sharing on employees with diabetes. Am J Manag Care. 2006;12:SP20-SP26. (Pubitemid 46053392)
33. Fitch K, Iwasaki K, Pyenson B. Value-Based Insurance Designs for Diabetes Drug Therapy: Actuarial and Implementation Considerations. New York: Milliman; 2008.
34. Spaulding A, Fendrick AM, Herman WH, et al. A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci. 2009;4:19.
35. Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 2009;119(3):390-397.
36. Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. Santa Monica, CA: The RAND Corporation; 2009